119 related articles for article (PubMed ID: 24191714)
1. Promoter hypermethylation of BCL6B gene is a potential plasma DNA biomarker for gastric cancer.
Yang Q; Gao J; Xu L; Zeng Z; Sung JJ; Yu J
Biomarkers; 2013 Dec; 18(8):721-5. PubMed ID: 24191714
[TBL] [Abstract][Full Text] [Related]
2. Epigenetic inactivation of BCL6B, a novel functional tumour suppressor for gastric cancer, is associated with poor survival.
Xu L; Li X; Chu ES; Zhao G; Go MY; Tao Q; Jin H; Zeng Z; Sung JJ; Yu J
Gut; 2012 Jul; 61(7):977-85. PubMed ID: 21917650
[TBL] [Abstract][Full Text] [Related]
3. Detection of aberrant methylation as a tumor marker in serum of patients with gastric cancer.
Ichikawa D; Koike H; Ikoma H; Ikoma D; Tani N; Otsuji E; Kitamura K; Yamagishi H
Anticancer Res; 2004; 24(4):2477-81. PubMed ID: 15330201
[TBL] [Abstract][Full Text] [Related]
4. Hypermethylation of the CpG islands in the promoter region flanking GSTP1 gene is a potential plasma DNA biomarker for detecting prostate carcinoma.
Chuang CK; Chu DC; Tzou RD; Liou SI; Chia JH; Sun CF
Cancer Detect Prev; 2007; 31(1):59-63. PubMed ID: 17291695
[TBL] [Abstract][Full Text] [Related]
5. Potential diagnostic and prognostic values of detecting promoter hypermethylation in the serum of patients with gastric cancer.
Leung WK; To KF; Chu ES; Chan MW; Bai AH; Ng EK; Chan FK; Sung JJ
Br J Cancer; 2005 Jun; 92(12):2190-4. PubMed ID: 15942635
[TBL] [Abstract][Full Text] [Related]
6. Reprimo as a potential biomarker for early detection in gastric cancer.
Bernal C; Aguayo F; Villarroel C; Vargas M; Díaz I; Ossandon FJ; Santibáñez E; Palma M; Aravena E; Barrientos C; Corvalan AH
Clin Cancer Res; 2008 Oct; 14(19):6264-9. PubMed ID: 18829507
[TBL] [Abstract][Full Text] [Related]
7. Detection of gene promoter hypermethylation in the tumor and serum of patients with gastric carcinoma.
Lee TL; Leung WK; Chan MW; Ng EK; Tong JH; Lo KW; Chung SC; Sung JJ; To KF
Clin Cancer Res; 2002 Jun; 8(6):1761-6. PubMed ID: 12060614
[TBL] [Abstract][Full Text] [Related]
8. Distinct promoter hypermethylation of p16INK4a, CDH1, and RAR-beta in intestinal, diffuse-adherent, and diffuse-scattered type gastric carcinomas.
Oue N; Motoshita J; Yokozaki H; Hayashi K; Tahara E; Taniyama K; Matsusaki K; Yasui W
J Pathol; 2002 Sep; 198(1):55-9. PubMed ID: 12210063
[TBL] [Abstract][Full Text] [Related]
9. Promoter hypermethylation of multiple genes in early gastric adenocarcinoma and precancerous lesions.
Zou XP; Zhang B; Zhang XQ; Chen M; Cao J; Liu WJ
Hum Pathol; 2009 Nov; 40(11):1534-42. PubMed ID: 19695681
[TBL] [Abstract][Full Text] [Related]
10. Promoter hypermethylation of cyclooxygenase-2 in gastric carcinoma.
Yu J; Leung WK; Lee TL; Tse PC; To KF; Sung JJ
Int J Oncol; 2003 May; 22(5):1025-31. PubMed ID: 12684668
[TBL] [Abstract][Full Text] [Related]
11. Clinical application of methylation specific-polymerase chain reaction in serum of patients with gastric cancer.
Ikoma H; Ichikawa D; Daito I; Nobuyuki T; Koike H; Okamoto K; Ochiai T; Ueda Y; Yamagishi H; Otsuji E
Hepatogastroenterology; 2007; 54(75):946-50. PubMed ID: 17591100
[TBL] [Abstract][Full Text] [Related]
12. Correlation between the single-site CpG methylation and expression silencing of the XAF1 gene in human gastric and colon cancers.
Zou B; Chim CS; Zeng H; Leung SY; Yang Y; Tu SP; Lin MC; Wang J; He H; Jiang SH; Sun YW; Yu LF; Yuen ST; Kung HF; Wong BC
Gastroenterology; 2006 Dec; 131(6):1835-43. PubMed ID: 17087954
[TBL] [Abstract][Full Text] [Related]
13. Quantification of plasma cell-free DNA in patients with gastric cancer.
Sai S; Ichikawa D; Tomita H; Ikoma D; Tani N; Ikoma H; Kikuchi S; Fujiwara H; Ueda Y; Otsuji E
Anticancer Res; 2007; 27(4C):2747-51. PubMed ID: 17695442
[TBL] [Abstract][Full Text] [Related]
14. Hypermethylation downregulates Runx3 gene expression and its restoration suppresses gastric epithelial cell growth by inducing p27 and caspase3 in human gastric cancer.
Chen W; Gao N; Shen Y; Cen JN
J Gastroenterol Hepatol; 2010 Apr; 25(4):823-31. PubMed ID: 20492341
[TBL] [Abstract][Full Text] [Related]
15. Detection of RASSF1A promoter hypermethylation in serum from gastric and colorectal adenocarcinoma patients.
Wang YC; Yu ZH; Liu C; Xu LZ; Yu W; Lu J; Zhu RM; Li GL; Xia XY; Wei XW; Ji HZ; Lu H; Gao Y; Gao WM; Chen LB
World J Gastroenterol; 2008 May; 14(19):3074-80. PubMed ID: 18494062
[TBL] [Abstract][Full Text] [Related]
16. Inactivation of O6-methylguanine-DNA methyltransferase by promoter CpG island hypermethylation in gastric cancers.
Bae SI; Lee HS; Kim SH; Kim WH
Br J Cancer; 2002 Jun; 86(12):1888-92. PubMed ID: 12085181
[TBL] [Abstract][Full Text] [Related]
17. DNA methylation profile in diffuse type gastric cancer: evidence for hypermethylation of the BRCA1 promoter region in early-onset gastric carcinogenesis.
Bernal C; Vargas M; Ossandón F; Santibáñez E; Urrutia J; Luengo V; Zavala LF; Backhouse C; Palma M; Argandoña J; Aguayo F; Corvalán A
Biol Res; 2008; 41(3):303-15. PubMed ID: 19399343
[TBL] [Abstract][Full Text] [Related]
18. Promoter hypermethylation and silencing of CHFR mitotic stress checkpoint gene in human gastric cancers.
Kang HC; Kim IJ; Park JH; Shin Y; Park HW; Ku JL; Yang HK; Lee KU; Choe KJ; Park JG
Oncol Rep; 2004 Jul; 12(1):129-33. PubMed ID: 15201973
[TBL] [Abstract][Full Text] [Related]
19. Quantitative detection of promoter hypermethylation of multiple genes in the tumor, urine, and serum DNA of patients with renal cancer.
Hoque MO; Begum S; Topaloglu O; Jeronimo C; Mambo E; Westra WH; Califano JA; Sidransky D
Cancer Res; 2004 Aug; 64(15):5511-7. PubMed ID: 15289362
[TBL] [Abstract][Full Text] [Related]
20. The survival decrease in gastric cancer is associated with the methylation of B-cell CLL/lymphoma 6 member B promoter.
Deng J; Liang H; Dong Q; Hou Y; Xie X; Yu J; Fan D; Hao X
Open Biol; 2014 Jul; 4(7):. PubMed ID: 25008234
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]